MADELEINE LABRIE: Open Payments
NPI 1013517168 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 45 payments from 7 companies in 2025. Trend: 2023 $1,020 · 2024 $1,731 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $270 |
| Medtronic, Inc. | 5 | $186 |
| Collegium Pharmaceutical, Inc. | 20 | $163 |
| Forte Bio-Pharma LLC | 4 | $68 |
| Valinor Pharma, LLC | 2 | $35 |
| AppliedVR Inc | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
Products named: RELISTOR, INTELLIS ADAPTIVESTIM, Belbuca, PROLATE, MOVANTIK, RelieVRx, JOURNAVX, VANTA ADAPTIVESTIM.
Industry payments across OK — which companies pay providers there.
